Journals / ANKEM Dergisi / 2006 / Cilt: 20 - Sayı: 2

Pneumococcal infections and prevention

Pnömokok infeksiyonları ve korunma

Pages
125–132
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, pneumococcal infections, the role of host defence mechanisms and the bacterial virulence factors, the present knowledge on pneumococcal vaccines and the recent developments in novel vaccine strategies were discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Streptococcus pneumoniae is a major cause of invasive diseases such as meningitis, pneumonia, septicaemia and respiratory tract infections like otitis media and sinusitis.
📊
Key Findings & Data:Despite of the availability of excellent antimicrobial therapy and adequate health care systems, the morbidity and mortality of pneumococcal infections are still high.
💡
Conclusion & Impact:In this article, pneumococcal infections, the role of host defence mechanisms and the bacterial virulence factors, the present knowledge on pneumococcal vaccines and the recent developments in novel vaccine strategies were discussed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Pnömokok enfeksiyonları · Streptococcus pneumoniae · Pneumococcal Infections

Abstract

Streptococcus pneumoniae is a major cause of invasive diseases such as meningitis, pneumonia, septicaemia and respiratory tract infections like otitis media and sinusitis. Despite of the availability of excellent antimicrobial therapy and adequate health care systems, the morbidity and mortality of pneumococcal infections are still high. On the other hand, the emerging resistance to penicillin and other commonly used antibiotics has become a worldwide problem. Therefore, prevention of pneumococcal disease has become of great interest recently. In this article, pneumococcal infections, the role of host defence mechanisms and the bacterial virulence factors, the present knowledge on pneumococcal vaccines and the recent developments in novel vaccine strategies were discussed.

Özet

Streptococcus pneumoniae, menenjit, pnömoni ve septisemi gibi invaziv hastalıkların, otitis media ve sinüzit gibi solunum yolu infeksiyonlarının önemli bir nedenidir. Antimikrobiyal tedavideki yeni gelişmelere ve uygun izleme rağmen pnömokoksik infeksiyonların morbidite ve mortalitesi halen yüksektir. Bunun yanısıra penisilin ve diğer kullanılan antibiyotiklere karşı direnç tüm dünyada önemli bir sorundur. Bu nedenle, son yıllarda pnömokoksik infeksiyonlardan korunma konusuna olan ilgi yoğunlaşmıştır. Bu yazıda, pnömokoksik infeksiyonlar, infeksiyon gelişiminde rol oynayan konak savunma mekanizmaları ve bakteriyel virülans faktörleri, kullanımda olan ve yeni geliştirilen pnömokok aşıları ve aşı stratejilerindeki yeni gelişmeler tartışılmıştır.

🔖

Cite This Article

TÜNGER, Ö. (2006). Pneumococcal infections and prevention. ANKEM Dergisi, Cilt: 20 - Sayı: 2, 125–132. https://ajindex.com/articles/355077

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Advisory Committee on Immunization Practices (ACIP): (Recommendations) Preventing pneumococcal disease among infants and young children, MMWR Recomm Rep 2000;49 (RR-9):1-35
  2. Arditi M, Yogev R: Common etiologic agent of bacterial meningitis, “Shulman ST, Phair JP, Peterson LR, Warren JR (eds): The Biologic and Clinical Basis of Infectious Diseases, 5.baskı” kitabında s.310-26, WB Saunders, Philadelphia (1997)
  3. Austrian R: Pneumococcal polysaccharide vaccines, Rev Infect Dis 1989;11(Suppl 3):S598-602
  4. Austrian R: The pneumococcus at the millennium: not down, not out, J Infect Dis 1999;179(Suppl 2):S338-41
  5. Austrian R: Pneumococcal otitis media and pneumococcal vaccines, a historical perspective, Vaccine 2000;19 (Suppl 1):S71-7
  6. BennettD, Lennon B,Humphreys H, Cafferkey M: Penicillin susceptibility and epidemiological typing of invasive pneumococcal isolates in the Republic of Ireland, J Clin Microbiol 2003;41(8):3641-8
  7. BogaertD,HermansPWM,Adrian PV,RümkeHC,deGrootR:Pneumococcal vaccines: an update on current strategies,Vaccine 2004;22(17-18):2209- 20
  8. Briles DE, Ades E, Paton JC et al: Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae, Infect Immun 2000;68(2):796-800
  9. Briles DE, Hollingshead SK, Brooks-Walter A et al: The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection, Vaccine 2000;18(16):1707-11
  10. Bruyn GA, Zegers BJ, van Furth R:Mechanisms of host defense against infection with Streptococcus pneumoniae, Clin Infect Dis 1992;14 (1): 251-62
  11. Butler JC, Shapiro ED, Carlone GM: Pneumococcal vaccines: history, current status, and future directions,Am J Med 1999;107(1A):S69-76
  12. CartwrightK: Pneumococcal disease inwestern Europe: burden of disease, antibiotic resistance and management, Eur J Pediatr 2002;161(4):188-95
  13. Dagan R, Givon-Lavi N, Zamir O et al: Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers, J Infect Dis 2002;185(7):927-36
  14. Deeks SL, Palacio R, Ruvinsky R et al: Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae, The Streptococcus pneumoniaeWorking Group, Pediatrics 1999;103(2):409-13
  15. DurbinWJ: Pneumococcal infections, Pediatr Rev 2004;25(12):41